Daptomycin and vancomycin of similar value in MRSA infection

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.542, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daptomycin and vancomycin of similar value in MRSA infection

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Daptomycin/vancomycin: Development of daptomycin-non-susceptible MRSA leading to fatal bacteraemia: case report

Reactions Weekly, Vol. 1, Iss. 1247-1248, 2009-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Teicoplanin/vancomycin: Daptomycin-nonsusceptible, vancomycin-intermediate MRSA leading to fatal bacteraemic mycotic aneurysm and renal failure: case report

Reactions Weekly, Vol. 1, Iss. 1259, 2009-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Vancomycin: Treatment failure in MRSA infection in a patient with neutropenia: case report

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 44-45

Adis International

Access to resources Recommend Favorite

Daptomycin/linezolid/vancomycin: Anaphylactic reaction, elevated creatine kinase levels and emergence of multidrug resistant MRSA in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1406, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite